Log In
BCIQ
Print this Print this
 

CER006

  Manage Alerts
Collapse Summary General Information
Company Ceridia Pty. Ltd.
DescriptionIbuprofen formulation using Ceridia's LipoCeramic nanoparticle encapsulation technology
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationPain
Indication DetailsTreat pain
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today